We noticed that the 4 proteins of MIG6, CD26, NF2, and INPP4B linked the lung carcinoma subtypes directly, indicating that these 4 protein biomarkers may aid in distinguishing between different subtypes of tumors and guide therapeutic decision-making. The gene discussed is DPP4; the disease is lung carcinoma.